Treating Blood Cancers

By: The Leukemia & Lymphoma Society
Listen for free

  • Summary

  • LLS Podcast Series for Professionals
    2019 Treating Blood Cancers Podcast Series - The Leukemia & Lymphoma Society
    Show More Show Less
Hygiene & Healthy Living Nature & Ecology Physical Illness & Disease
Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • What’s New in Chronic Lymphocytic Leukemia (CLL)?

    What’s New in Chronic Lymphocytic Leukemia (CLL)?
    Nov 19 2024
    Kerry A. Rogers, MD, The Ohio State University, Columbus, OH Recorded on October 29, 2024 Kerry A. Rogers, MD Associate Professor Division of Hematology The Ohio State University Columbus, OH Tune in for this comprehensive overview of Chronic Lymphocytic Leukemia (CLL) with Dr. Kerry Rogers from The Ohio State University. She covers key risk factors, signs and symptoms, and the critical decision-making process between monitoring and initiating treatment. Also explored are treatment goals with consideration to how strategies may vary for different subsets of patients, and discussion on new therapies. Additionally, Dr. Rogers addresses side effect management and resources available to support both patients and their families. Listen to this informative episode today!
    Show More Show Less
    35 mins
  • The Role of the Healthcare Team in Biomarker Testing

    The Role of the Healthcare Team in Biomarker Testing
    Oct 25 2024
    Jennifer R. Rushton, MD, Clinical Pathology Associates and the Baptist Health System, San Antonio, TX and Eric Severson, MD, PhD, Labcorp Oncology, Shelton, CT Recorded on July 2, 2024 Join us, as we dive into the crucial topic of biomarker testing with Dr. Jennifer Rushton from Clinical Pathology Associates and the Baptist Health System, and Dr. Eric Severson from Labcorp Oncology. They explore the role of the healthcare team in integrating biomarker testing into clinical practice and decision-making, as well as strategies for effective patient communication about its importance and implications. They also share their perspectives on the future of biomarker testing. Tune in today to learn more! Jennifer R. Rushton, MD Clinical Pathology Associates Medical Director, Pathology and Laboratory Medicine Baptist Health System San Antonio, TX Eric Severson, MD, PhD Executive Director Medical Affairs and Evidence Generation Labcorp Oncology Shelton, CT This episode is supported by Labcorp Oncology.
    Show More Show Less
    30 mins
  • Decoding Medicare for Healthcare Professionals

    Decoding Medicare for Healthcare Professionals
    Oct 11 2024
    Stacie B. Dusetzina, PhD, Vanderbilt University Medical Center, Nashville, TN and Bethany Lilly, JD, The Leukemia & Lymphoma Society, Rye Brook, NY Recorded on September 20, 2024 Tune in to this informative episode as Dr. Stacie Dusetzina from Vanderbilt University and Bethany Lilly from The Leukemia & Lymphoma Society’s Office of Public Policy simplify the complexities of Medicare, and how healthcare professionals can help their patients navigate these decisions for better care outcomes. They discuss how plan choices affect access to cancer treatment and the financial burden of high-cost medications. They also examine the recent changes brought by the Inflation Reduction Act and what they mean for Medicare beneficiaries. Listen today to learn more about helping your patients make informed decisions, including helpful resources, in this important aspect of healthcare! Stacie B. Dusetzina, PhD Professor, Health Policy Ingram Professor of Cancer Research Vanderbilt University Medical Center Nashville, TN Bethany Lilly, JD Executive Director, Public Policy The Leukemia & Lymphoma Society Rye Brook, NY Resources mentioned in this episode:
    Show More Show Less
    35 mins

What listeners say about Treating Blood Cancers

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available